Kalland T - Search Results

1

Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer.

Giantonio BJ, Alpaugh RK, Schultz J, McAleer C, Newton DW, Shannon B, Guedez Y, Kotb M, Vitek L, Persson R, Gunnarsson PO, Kalland T, Dohlsten M, Persson B, Weiner LM. Giantonio BJ, et al. Among authors: kalland t. J Clin Oncol. 1997 May;15(5):1994-2007. doi: 10.1200/JCO.1997.15.5.1994. J Clin Oncol. 1997. PMID: 9164211 Clinical Trial.

2

Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.

Lando PA, Olsson C, Kalland T, Newton D, Kotb M, Dohlsten M. Lando PA, et al. Among authors: kalland t. J Immunol. 1996 Oct 1;157(7):2857-63. J Immunol. 1996. PMID: 8816390

3

Immune response during tumor therapy with antibody-superantigen fusion proteins.

Rosendahl A, Hansson J, Sundstedt A, Kalland T, Dohlsten M. Rosendahl A, et al. Among authors: kalland t. Int J Cancer. 1996 Sep 27;68(1):109-13. doi: 10.1002/(SICI)1097-0215(19960927)68:1<109::AID-IJC19>3.0.CO;2-6. Int J Cancer. 1996. PMID: 8895549

4

Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo.

Dohlsten M, Hansson J, Ohlsson L, Litton M, Kalland T. Dohlsten M, et al. Among authors: kalland t. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9791-5. doi: 10.1073/pnas.92.21.9791. Proc Natl Acad Sci U S A. 1995. PMID: 7568219 Free PMC article.

5

Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells.

Holzer U, Bethge W, Krull F, Ihle J, Handgretinger R, Reisfeld RA, Dohlsten M, Kalland T, Niethammer D, Dannecker GE. Holzer U, et al. Among authors: kalland t. Cancer Immunol Immunother. 1995 Aug;41(2):129-36. doi: 10.1007/BF01527409. Cancer Immunol Immunother. 1995. PMID: 7656271 Free PMC article.

6

Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells.

Hedlund G, Dohlsten M, Petersson C, Kalland T. Hedlund G, et al. Among authors: kalland t. Cancer Immunol Immunother. 1993;36(2):89-93. doi: 10.1007/BF01754407. Cancer Immunol Immunother. 1993. PMID: 8425213 Free PMC article.

7

Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.

Newton DW, Dohlsten M, Olsson C, Segrén S, Lundin KE, Lando PA, Kalland T, Kotb M. Newton DW, et al. Among authors: kalland t. J Immunol. 1996 Nov 1;157(9):3988-94. J Immunol. 1996. PMID: 8892632

8

T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant.

Holzer U, Orlikowsky T, Zehrer C, Bethge W, Dohlsten M, Kalland T, Niethammer D, Dannecker GE. Holzer U, et al. Among authors: kalland t. Immunology. 1997 Jan;90(1):74-80. doi: 10.1046/j.1365-2567.1997.00141.x. Immunology. 1997. PMID: 9038715 Free PMC article.

9

A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies.

Gidlöf C, Dohlsten M, Lando P, Kalland T, Sundström C, Tötterman TH. Gidlöf C, et al. Among authors: kalland t. Blood. 1997 Mar 15;89(6):2089-97. Blood. 1997. PMID: 9058731 Free article.

10

MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.

Newton DW, Dohlsten M, Lando PA, Kalland T, Olsson C, Kotb M. Newton DW, et al. Among authors: kalland t. Int J Mol Med. 1998 Jan;1(1):157-62. doi: 10.3892/ijmm.1.1.157. Int J Mol Med. 1998. PMID: 9852214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters